+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

B-cell Lymphoma- Pipeline Insight, 2025 - Product Thumbnail Image

B-cell Lymphoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Nordic Biotechnology - Industry Report - Product Thumbnail Image

Nordic Biotechnology - Industry Report

  • Report
  • September 2025
  • 370 Pages
  • Denmark, Finland, ... Denmark, Finland, Iceland, Norway, Sweden
From
Waldenstrom Macroglobulinemia - Pipeline Insight, 2025 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Pituitary Cancer - Global Strategic Business Report - Product Thumbnail Image

Pituitary Cancer - Global Strategic Business Report

  • Report
  • September 2025
  • 575 Pages
  • Global
From
From
From
Precision Oncology - Global Strategic Business Report - Product Thumbnail Image

Precision Oncology - Global Strategic Business Report

  • Report
  • September 2025
  • 382 Pages
  • Global
From
From
NUT Midline Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

NUT Midline Carcinoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 383 Pages
  • Global
From
Breast Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Breast Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 294 Pages
  • Global
From
Lung Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Lung Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 291 Pages
  • Global
From
From
Blockbuster Oncology Brands - Global Strategic Business Report - Product Thumbnail Image

Blockbuster Oncology Brands - Global Strategic Business Report

  • Report
  • September 2025
  • 284 Pages
  • Global
From
IgA Nephropathy Market - Global Forecast 2025-2030 - Product Thumbnail Image

IgA Nephropathy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Urea Cycle Disorder Agent Market - Global Forecast 2025-2030 - Product Thumbnail Image

Urea Cycle Disorder Agent Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Loading Indicator